THE IMPACT OF INTERHOSPITAL TRANSFER ON MORTALITY BENCHMARKING AT LEVEL III AND IV TRAUMA CENTERS: A STEP TOWARDS SHARED MORTALITY ATTRIBUTION IN A STATEWIDE SYSTEM.
Many injured patients presenting to level III/IV trauma centers will be transferred to level I/II centers, but how these transfers influence benchmarking at level III/IV centers has not been described. We hypothesized that the apparent observed to expected (O:E) mortality ratios at level III/IV centers are influenced by the location at which mortality is measured in transferred patients. We conducted a retrospective study of adult patients presenting to Level III/IV trauma centers in Pennsylvania from 2008-2017. We used probabilistic matching to match patients transferred between centers. We used a risk-adjusted mortality model to estimate predicted mortality, which we compared to observed mortality at discharge from the level III/IV center (O) or observed mortality at discharge from the level III/IV center for non-transferred patients and at discharge from the level I/II center for transferred patients (O). In total, 9,477 patients presented to 11 Level III/IV trauma centers over the study period (90% white, 49% female, 97% blunt mechanism, median ISS 8 IQR (4-10). Of these, 4,238 (44%) were transferred to Level I/II centers, of which 3,586 (85%) were able to be matched. Expected mortality in the overall cohort was 332 (3.8%). A total of 332 (3.8%) patients died, of which 177 (53%) died at the initial level III/IV centers (O). Including post-transfer mortality for transferred patients in addition to observed mortality in non-transferred patients (O) resulted in worse apparent O:E ratios for all centers and significant differences in O:E ratios for the overall cohort (O:E: 0.53, 95% CI 0.45-0.61 vs. O:E: 1.00, 95% CI 0.92-1.11, p<0.001). Apparent O:E mortality ratios at level III/IV centers are influenced by the timing of measurement. To provide fair and accurate benchmarking and identify opportunities across the continuum of the trauma system, a system of shared attribution for outcomes of transferred patients should be devised. Level 3: Retrospective cohort study.